Stay updated on AGI-134 Safety & Tolerability in Solid Tumour Clinical Trial

Sign up to get notified when there's something new on the AGI-134 Safety & Tolerability in Solid Tumour Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AGI-134 Safety & Tolerability in Solid Tumour Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A site-wide status notice about funding lapses and NIH operations was added, directing users to cc.nih.gov and opm.gov for updates. The page revision history also shows a new version tag (v3.4.1) and removal of the previous v3.4.0.
    Difference
    0.4%
    Check dated 2026-02-04T05:18:51.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Glossary display added; QC metadata labeling updated to revision v3.4.0.
    Difference
    0.2%
    Check dated 2026-01-28T03:19:43.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and Revision: v3.3.3 was removed from the page.
    Difference
    0.1%
    Check dated 2026-01-14T01:54:22.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    - Added a Locations section listing California, New Jersey, and Oregon sites, with the page revision updated to v3.3.3; the HHS Vulnerability Disclosure link was removed.
    Difference
    0.4%
    Check dated 2025-12-23T17:25:43.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.3.2, replacing the previous Revision: v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-24T21:22:38.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    - Removed the government funding status notice from the page. The core study details remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-17T19:16:22.000Z thumbnail image

Stay in the know with updates to AGI-134 Safety & Tolerability in Solid Tumour Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AGI-134 Safety & Tolerability in Solid Tumour Clinical Trial page.